Vanguard Information Technology ETF (VGT)
| Assets | $114.72B |
| Expense Ratio | 0.09% |
| PE Ratio | 39.08 |
| Shares Out | 148.20M |
| Dividend (ttm) | $3.07 |
| Dividend Yield | 0.40% |
| Ex-Dividend Date | Sep 24, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 15.61% |
| Volume | 745,414 |
| Open | 778.07 |
| Previous Close | 777.66 |
| Day's Range | 758.61 - 778.69 |
| 52-Week Low | 451.00 |
| 52-Week High | 806.99 |
| Beta | 1.26 |
| Holdings | 317 |
| Inception Date | Jan 26, 2004 |
About VGT
Fund Home PageThe Vanguard Information Technology ETF (VGT) is an exchange-traded fund that mostly invests in information technology equity. The fund tracks a market cap-weighted index of companies in the US information technology sector. VGT was launched on Jan 26, 2004 and is issued by Vanguard.
Top 10 Holdings
57.65% of assets| Name | Symbol | Weight |
|---|---|---|
| NVIDIA Corporation | NVDA | 17.17% |
| Apple Inc. | AAPL | 13.36% |
| Microsoft Corporation | MSFT | 13.10% |
| Broadcom Inc. | AVGO | 4.47% |
| Oracle Corporation | ORCL | 2.35% |
| Palantir Technologies Inc. | PLTR | 2.02% |
| Cisco Systems, Inc. | CSCO | 1.39% |
| Advanced Micro Devices, Inc. | AMD | 1.33% |
| International Business Machines Corporation | IBM | 1.33% |
| Salesforce, Inc. | CRM | 1.14% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 24, 2025 | $0.8586 | Sep 26, 2025 |
| Jun 26, 2025 | $0.7028 | Jun 30, 2025 |
| Mar 25, 2025 | $0.7294 | Mar 27, 2025 |
| Dec 18, 2024 | $0.7766 | Dec 20, 2024 |
| Sep 27, 2024 | $0.9171 | Oct 1, 2024 |
| Jun 28, 2024 | $0.7624 | Jul 2, 2024 |
Performance
VGT had a total return of 28.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.45%.
News
VGT: The Technology Sector's Uptrend Is Likely To Continue Despite Trade War Concerns
Vanguard Information Technology Index Fund ETF Shares (VGT) earns a buy rating due to strong earnings growth and robust US economic outlook. The US stock market's uptrend is fueled by better-than-expe...
VGT: A Non-Negotiable Part Of My Portfolio
Vanguard Information Technology Index Fund ETF is an essential, diversified tech holding, outperforming benchmarks and capturing sector evolution. VGT's market-cap weighting ensures top performers lik...
Worldwide Exchange: ETF Flows Week of September 29
CNBC's Frank Holland speaks with Robert Doll, CEO & CIO at Crossmark Global Investments, about the action in ETFs this week.
Hold XLK, Buy VGT: How To Stay In Tech Without Being Dependent On 3 Ticker Symbols
Vanguard Information Technology Index Fund ETF Shares, VGT, offers broader tech exposure and less concentration risk than The Technology Select Sector SPDR® Fund ETF, XLK. VGT includes 300 stocks, pro...
BlackRock Makes a Quantum Leap Into an AI ETF
Weekly trading in large ETFs often makes it difficult to spot a clear pattern. However, the $22 billion iShares U.S. Technology ETF (IYW) was an exception last week .According to ETF Database, IYW exp...
How Active Tech ETF GTEK Has Outperformed VGT YTD
Active ETFs have become a key part of the investing landscape for retail investors and institutional investors, alike.
TECB's Edge Over VGT: Capturing Additional Growth In The Tech Industry
TECB offers diversified exposure to five high-growth tech themes with lower valuation multiples than VGT. VGT provides stability through mega-cap leaders but is highly concentrated in its top holdings...
VGT Is Not A Victim Of Nvidia
VGT offers broad IT sector exposure, but is heavily weighted toward NVDA and top 10 holdings, reducing true diversification. NVDA's growth is in line with consensus, but buybacks and conservative guid...
VGT: Can't Be Rattled, Surprising Value, Buy And Don't Look Back
I upgrade VGT to a long-term buy due to its strong fundamentals, robust earnings, and leadership in tech innovation. VGT offers broad, pure tech exposure with low expenses and diversification beyond t...
The Best Tech ETFs to Buy
Tech ETFs can deliver superb tax efficiency and growth potential, but investors must be aware of high volatility, concentration risk and stretched valuations.
VGT: The Nasdaq King That Could Deliver An Epic Rally
VGT is poised for a tech rally, with $90-110B in systematic flows likely and strong earnings growth from AI and cloud leaders. Favorable macro conditions—low volatility, resilient big tech earnings, a...
VGT: Passive Tech Needs A Better Screen
Vanguard Information Technology Index Fund ETF Shares offers a tech-focused ETF, but its methodology excludes key growth names like Amazon and Google, limiting its appeal for my ideal portfolio. The f...
Vergent Bioscience Presents Phase 2B VISUALIZE Results Demonstrating Abenacianine for Injection (VGT-309) with Intraoperative Molecular Imaging Improved Tumor Visualization During Lung Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor targeted imaging agents, announced new data being presented at the 2025 American Society of Cl...
VGT Vs. QQQ: Which Is The Best Growth ETF?
VGT offers slightly lower fees and broader tech sector exposure, but is more top-heavy and excludes major tech names like Amazon, Google, and Meta. QQQ provides access to the full Magnificent 7, is le...
VGT: I Want More Diversification
VGT's extreme concentration in its top three holdings undermines the diversification benefit I expect from an ETF. Current tech sector valuations are historically high, leaving little room for further...
Vergent Bioscience to Present Data on Abenacianine for Injection (VGT-309) at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that an abstract on abenacianine for injection (VGT-309) wi...
Tips for investing in tech now
Big tech has dominated the markets, but with tariffs and market uncertainty, what should investors do with the sector now? Ivana Delevska, Spear Invest Founder and CIO, joins Wealth to give some tips ...
VGT: In A Rut, Mixed Analysis, Hold Tight
Vanguard Information Technology Index Fund (VGT) is down 12% in the last month but has gained 3.5% over the last year. VGT is heavily weighted in Apple, Nvidia, and Microsoft, which account for nearly...
VGT: Great Opportunity To Buy The Tech Giants
VGT has outperformed the SP500 with an average return of 15.52% since 2004, despite recent volatility and a 24.12% loss this year. The ETF is heavily concentrated in tech giants like AAPL, NVDA, and M...
VGT: Vanguard's IT ETF - Buy The Sell-Off (Fortune Favors The Bold)
VGT ETF is down 11.8% YTD but boasts a strong 19.8% average annual return over the past decade, outperforming the S&P500 by ~7% annually. VGT is well-diversified across critical tech sub-sectors like ...
VGT: Has Become Expensive, Yet (Almost) Everyone Still Wants It
VGT is a leading tech ETF with a competitive Sharpe ratio, even compared to the Nasdaq and other Information Technology ETFs. VGT, like the Information Technology sector, has a negative current and fo...
Avoid the QQQ ETF, buy this Nasdaq 100 ETF alternative instead
The Invesco QQQ ETF has become one of the best-performing funds in the United States in the past few decades by tracking the Nasdaq 100 index. It has soared from about $40 during its inception and mov...
AI-themed ETFs plunge in wake of DeepSeek news
Prices of exchange-traded funds with outsize exposure to Nvidia plunged in the initial hours of trading on Monday in reaction to news that a Chinese startup has launched a powerful new artificial inte...
XSW Seems Better Than VGT In The Age Of DOGE
The SPDR S&P Software & Services ETF outperformed the Vanguard Information Technology Index Fund ETF due to anticipated growth in mid- and small-cap tech companies benefiting from deregulation. XSW's ...
VGT: The Only One To Hold
The technology sector, despite slowing earnings growth, remains attractive due to solid future earnings expectations and AI potential, with Vanguard Information Technology Index Fund ETF Shares (VGT) ...
Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that the U.S. Food & Drug Administration (FDA) has granted ...
VGT: Promising Long-Term Outlook With Short-Term Uncertainty
The tech sector thrived in 2024, with standout performances from Apple, Microsoft, and Nvidia, but potential volatility looms ahead. VGT is highly concentrated in its top three holdings, which poses r...
VGT: Why It Is A Strong Large Growth ETF
VGT has outperformed other large-cap ETFs like SPY and QQQ, making it a top recommendation for long-term holding due to its technology focus. Technology is the key growth driver, with ETFs like VGT ma...
VGT: Tech Stocks Look Tired
Mega-cap tech stocks have led the market, but VGT's heavy concentration in Apple, Microsoft, and NVIDIA poses risks if their charts turn bearish. VGT is not a diversified fund; nearly 60% of its holdi...
Vergent Bioscience Completes Enrollment in Phase 2 VISUALIZE Trial Evaluating Potential of Abenacianine for Injection (VGT-309) to Improve Tumor Visualization During Cancer Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company's Phase 2, ...
VGT: Less Attractive In An Era Of Mega Caps
VGT's concentrated portfolio, with Apple, Nvidia, and Microsoft at 45%, reduces diversification and limits upside potential to 6%. VGT tracks the MSCI US IMI/Information Technology 25/50 Index, which ...
VGT: A Fund For Technology's Next Big Run
VGT is a solid technology sector fund with a low expense ratio and superior risk-adjusted performance, despite slightly lagging its peers in total return. Technology's recent underperformance is due t...
VGT Is A Stronger Investment Option Than QQQ
VGT offers a competitive investment strategy with a lower expense ratio (10bps) and higher yield (0.65%) compared to QQQ, making it a strong buy for tech sector exposure. VGT's portfolio is highly con...
VGT: Relative Strength Suggests Caution Warranted
The Vanguard Information Technology ETF (VGT) is dominated by Apple, NVIDIA, and Microsoft, which together account for 44% of the ETF. The VGT ETF's recent underperformance relative to the S&P 500 sug...
VGT: Insane Concentration Risk
Tech is currently the most overcrowded sector, likely facing a meaningful correction soon, making it a risky allocation right now. Vanguard Information Technology ETF offers broad tech exposure but ha...
VOO, VGT, DIA ETF stocks suffered a harsh reversal: I'm buying
American stocks dived on Friday as concerns that the US was moving into a hard landing continued. The Vanguard S&P 500 ETF (VOO) ETF slumped to $490 on Friday, down by over 5.69% from its highest leve...
VGT: Sector-Specific Concentration And Long-Term Exposure
Exchange-Traded Funds can provide significant portfolio diversification, investing with long-term strategies. VGT is a top-heavy fund with holdings weighted in the Information Technology sector. The f...
VGT: A Higher-Risk Fund That Looks Overvalued Right Now
Vanguard Information Technology ETF has outperformed since 2004, but is heavily concentrated in a few large-cap tech companies. VGT has consistently underperformed the broader NASDAQ index, with core ...
Vergent Bioscience Data Published in The Annals of Thoracic Surgery Demonstrate VGT-309 May Help Surgeons Visualize Tumor Tissue in the Lung During Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that data published in The Annals of Thoracic Surgery reinf...
VGT: Buy This Basket With An Impressive Assortment Of Eggs
The current US economic landscape is unique. Many varying economic forces, making an ideal soft landing a matter of when. VGT has a unique portfolio concentrated enough to reap long-term benefits of t...